MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    The Contribution of APOE4 Genotype on Structural MRI in Parkinson’s Disease: A Study from the PPMI Cohort

    A. Rosal, A. Strafella, S. Martin (Toronto, Canada)

    Objective: To assess the contribution of Apolipoprotein E4 (APOE4) in Parkinson’s Disease (PD)-related cognitive impairment by analyzing its impact on Gray Matter Volume (GMV). Background:…
  • 2024 International Congress

    The alteration of GABA and glutamate in Parkinson’s disease is related to motor executive dysfunction: a 7T-MRS study

    D. Su, N. Wei, R. Yan, Z. Zhang, T. Feng (Beijing, China)

    Objective: To explore the possible metabolic alterations of primary motor cortices (M1) of Parkinson’s disease (PD) patients and prodromal PD using 7T proton magnetic resonance…
  • 2024 International Congress

    The Feasibility of ICA in Parkinson’s Disease fMRI

    A. Kim, K. Shivok, T. Liang, R. Sergott, L. Singanamala, I. Fayed, C. Matias, C. Wu, L. Krisa, M. Alizadeh (Villanova, USA)

    Objective: To report the feasibility of ICA on the BOLD signals of a Parkinson’s Disease patient. Background: ICA is a mathematical method to decompose multivariate…
  • 2024 International Congress

    Weight Changes After Deep Brain Stimulation for Parkinson’s Disease in The Registry for the Advancement of DBS in Parkinson’s Disease (RAD-PD)

    S. O'Shea, A. Berg, J. Jimenez-Shahed (New York, USA)

    Objective: To determine if weight changes occur after Deep Brain Stimulation (DBS) Surgery for Parkinson’s disease (PD). Background: PD patients lose weight with disease progression…
  • 2024 International Congress

    Long-term follow up of unilateral deep brain stimulation for Parkinson’s disease

    F. Sarmento, A. Daga, A. Wang, T. de Araujo, S. Aghili-Mehrizi, J. K. Wong (Gainesville, USA)

    Objective: To assess long-term effectiveness of unilateral Deep Brain Stimulation (DBS) in Parkinson’s disease (PD) patients with up to 14 months of follow-up Background: DBS…
  • 2024 International Congress

    Early Outcomes Support use of a Remote Cross-Border Surgical Centre for Deep Brain Stimulation in Parkinson’s Disease

    E. Donlon, S. Abdullah, F. Ronan, M. Garvey, N. Austin, E. Reynolds, F. Ruggieri, T. Lynch, C. Fearon, C. Moran, E. Pereira, R. Walsh (Dublin, Ireland)

    Objective: We describe the results of a unique cross border collaboration to deliver BDS for Parkinson's disease in Ireland. Background: Deep brain stimulation (DBS) of…
  • 2024 International Congress

    Video-based Machine Rating Model for MDS-UPDRS III in Parkinson’s disease: A Proof-of-concept Pilot Study

    X. Zhu, Z. Chen, Y. Ling, K. Ren, Y. Tan, J. Liu (Shanghai, China)

    Objective: To develop a video-based machine rating system for the Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) III. Background: MDS-UPDRS III…
  • 2024 International Congress

    Codesigning Tech with Patients – Insights from the Quantitative and Qualitative Analysis of Three Technologies used in Patients With Parkinson’s Disease

    D. Pérez-Rangel, M. H.G. Monje, S. Grosjean, M. Srp, L. Antunes, R. Bouça-Machado, R. Cacho, S. Domínguez, J. Inocentes, T. Lynch, A. Tsakanika, D. Fotiadis, G. Rigas, E. Ruzicka, J. Ferreira, A. Antonini, N. Malpica, T. Mestre, A. Sánchez-Ferro (Madrid, Spain)

    Objective: To evaluate the usability and acceptability of three different digital health technologies developed for Parkinson's disease (PD). Background: PD care requires meeting patients' changing…
  • 2024 International Congress

    Free-living digital mobility outcomes in Parkinson’s disease patients with and without freezing of gait: what can they tell us?

    P. Ginis, E. Gazit, C. Schlenstedt, H. Gassner, C. Hansen, A. Mirelman, L. Alcock, C. Becker, J. Aymerich, L. Rivera, C. Kirk, H. Hunter, I. Neatrour, J. Kudelka, H. Hildesheim, P. Goerrissen, M. Gordon, L. Delgado, B. Caulfield, M. Long, M. Gilat, L. Rochester, A. Yarnall, W. Maetzler, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)

    Objective: I) To compare digital mobility outcomes (DMOs) of free-living gait quality and quantity obtained over one week between people with Parkinson’s disease (PwPD) who…
  • 2024 International Congress

    Gait and turning during daily life across the spectrum of normal, prodromal, early and moderate Parkinson’s disease

    M. Mancini, V. Shah, P. Burgos, P. Carlson-Kuhta, L. Talman, M. Lim, J. Quinn, F. Horak (Portland, USA)

    Objective: To compare gait and turning quality during daily life in older adults, people with Rapid Eye Movement (REM) sleep behavior disorder (RBD) and people…
  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley